drugset / Trial / NCT02841137

Efficacy Study of Progesterone Tablet in Post-menopausal Women

NCT02841137

Phase 2 Completed 80 enrolled IBSA Institut Biochimique SA
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a phase II study intended to determine the effect of progesterone 5, 10 and 20 mg tablets compared to progesterone 100 mg capsules on the endometrial thickness of post-menopausal women under hormone therapy with estradiol.

Timeline

Start
2016-06
Primary completion
2017-08-02
Completion
2018-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 5 mg
Subject Progesterone Other / unclassified 10 mg
Subject Progesterone Other / unclassified 20 mg
Subject Progesterone Other / unclassified 100 mg

Indications

No indication recorded.